Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_assertion type Assertion NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_head.
- NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_assertion wasGeneratedBy ECO_0000203 NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_provenance.
- NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_assertion wasDerivedFrom befree-20150227 NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_provenance.
- NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_assertion SIO_000772 23934188 NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_provenance.
- NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_assertion evidence source_evidence_literature NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_provenance.
- NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_assertion description "[These findings demonstrate that miR-137 is a crucial regulator of cancer response to doxorubicin treatment, and they identify miR-137 as a highly promising target to reduce CAR-driven doxorubicin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993481.RAUrWNzgvlOenPffnNbvH6gUXv-1VeS3Fz1RK6H-k6lR8130_provenance.